| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 381,834 | 372,601 | 404,361 | 398,488 | | Cost of Revenue | (660,384) | 585,750 | 106,514 | 1,051,394 | | | Gross Profit | 1,042,218 | (213,149) | 297,847 | (652,906) | | | Operating Expenses | | Research Development | 1,797 | 3,494 | 5,171 | 78,305 | | Selling General and Administrative | 1,058,596 | (228,436) | 286,241 | (740,017) | | Non Recurring | 4,094 | 47,287 | 22,262 | 187,199 | | Others | 11,659 | 4,073 | 25,722 | 27,081 | | | | Total Operating Expenses | 1,076,146 | (173,582) | 339,396 | (447,432) | | | | Operating Income or Loss | (33,928) | (39,567) | (41,549) | (205,474) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,354 | 17,111 | (3,684) | (19,384) | | Earnings Before Interest And Taxes | (34,187) | (26,856) | (26,858) | (230,794) | | Interest Expense | 3,661 | (1,700) | 8,848 | 10,830 | | Income Before Tax | (37,848) | (25,156) | (35,706) | (241,624) | | Income Tax Expense | 1,010 | 956 | (3,415) | 17,828 | | Minority Interest | (25) | (106) |
-
| 2,032 | | | | Net Income From Continuing Ops | (38,752) | (26,218) | (32,291) | (259,452) | | | Non-recurring Events | | Discontinued Operations | (5,519) | (55,447) | 14,007 | (37,284) | | Extraordinary Items |
-
|
-
|
-
| (8,876) | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (44,402) | (81,665) | (18,284) | (305,612) | | Preferred Stock And Other Adjustments |
-
| (123) | 123 |
-
| | | Net Income Applicable To Common Shares | ($44,402) | ($81,788) | ($18,161) | ($305,612) |
|
0.02% Nasdaq 0.00%
Income Statement
